Skip to main content

Portfolio

Investment Principles
Investment Area
Investment Process
Portfolio
Project title
Research institute
Preclinical
Phase1
Phase2
Phase3
Licensure
Schistosomiasis Vaccine
●
●
Typhoid Conjugate Vaccine
●
●
Measles-Rubella MAP Vaccine
●
Group A Streptococcus Vaccine
●
Technology Transfer of Pentavalent Meningitis Conjugate Vaccine
●
●
●
Pentavalent Meningococcal Conjugate vaccine
●
●
●
Non-replicating Protein Nanoparticle-based Rotavirus Vaccine
●
Novel Cholera Conjugate Vaccine
●
Schistosomiasis Vaccine
Development stage:
Phase1, Phase2
Typhoid Conjugate Vaccine
Development stage:
Phase2, Phase3
Measles-Rubella MAP Vaccine
Development stage:
Preclinical
Group A Streptococcus Vaccine
Development stage:
Preclinical
Technology Transfer of Pentavalent Meningitis Conjugate Vaccine
Development stage:
Phase2, Phase3, Licensure
Pentavalent Meningococcal Conjugate vaccine
Development stage:
Phase2, Phase3, Licensure
Non-replicating Protein Nanoparticle-based Rotavirus Vaccine
Development stage:
Preclinical
Novel Cholera Conjugate Vaccine
Development stage:
Phase2
Project title
Research institute
Preclinical
Phase1
Phase2
Phase3
Licensure
Antimalarial Combination Therapy for Malaria Prevention
●
●
Continuous Manufacturing Process for Human Use Helminth Infection Treatment
●
●
Novel Antibiotic Combinations to Address AMR Burden in Neonatal Sepsis
●
●
Treatment Development for Severe Malaria
●
Antimalarial Combination Therapy for Malaria Prevention
Development stage :
Phase1, Phase2
Continuous Manufacturing Process for Human Use Helminth Infection Treatment
Development stage :
Phase2, Phase3
Novel Antibiotic Combinations to Address AMR Burden in Neonatal Sepsis
Development stage :
Phase3, Licensure
Treatment Development for Severe Malaria
Development stage :
Phase1
*WHO licensure prequalification
Project title
Research institute
Early Prototype Development/ Analytical Validation
Clinical Validation/ Usability Assessment
Licensure
AI-driven All-in-one Diagnostic Platform for Malaria Species Differentiation
●
●
POCT for COVID19, Influenza and RSV
●
●
POCT for Multidrug-Resistant TB
●
Rapid Diagnostic Test for Malaria Antigen
●
POCT for Sexually Transmitted Infections and Resistance
●
●
●
Handheld POCT for Sexually Transmitted Infections
●
POCT for Sexually Transmitted Infections
●
Rapid Diagnostic Test for Malaria Detection in Saliva Samples
●
●
AI-driven All-in-one Diagnostic Platform for Malaria Species Differentiation
Development stage:
Clinical Validation/ Usability Assessment, Licensure
POCT for COVID19, Influenza and RSV
Development stage:
Clinical Validation/ Usability Assessment
POCT for Multidrug-Resistant TB
Development stage:
Clinical Validation/ Usability Assessment
Rapid Diagnostic Test for Malaria Antigen
Development stage:
Clinical Validation/ Usability Assessment
POCT for Sexually Transmitted Infections and Resistance
Development stage:
Clinical Validation/ Usability Assessment
Handheld POCT for Sexually Transmitted Infections
Development stage:
Early Prototype Development/ Analytical Validation
POCT for Sexually Transmitted Infections
Development stage:
Early Prototype Development/ Analytical Validation
Rapid Diagnostic Test for Malaria Detection in Saliva Samples
Development stage:
Clinical Validation/ Usability Assessment
No information yet.
Project title
Research institute
Study Area / Country
The Impact of Digital Health Technologies on the Delivery of Maternal and Child Health Services
Uganda
Evaluating Digital Health Solutions for Laboratory Diagnosis of Endemic and Pandemic Diseases
Mozambique
Analyzing Digital Solutions for Health System Gaps in Crisis-Affected Areas
Ethiopia, Nepal, Kiribati
The Public-Health Assessment of Malawi’s One DigitiZed Infrastructure COVID-19 Study
Malawi
Evaluating Applicability of Digital tools for Infectious Disease Surveillance in Community
Nigeria
Quantifying the Added Value of Lunit Software in Advancing TB Elimination Efforts
Vietnam
Understanding the End-user Perspectives of Implementing TB-CAD in High TB Burden Settings and Improving Fitness-for-Use in Children
Mongolia, Vietnam
The Impact of Digital Health Technologies on the Delivery of Maternal and Child Health Services
Study Area / Country :
Uganda
Evaluating Digital Health Solutions for Laboratory Diagnosis of Endemic and Pandemic Diseases
Study Area / Country :
Mozambique
Analyzing Digital Solutions for Health System Gaps in Crisis-Affected Areas
Study Area / Country :
Ethiopia, Nepal, Kiribati
The Public-Health Assessment of Malawi’s One DigitiZed Infrastructure COVID-19 Study
Study Area / Country :
Malawi
Evaluating Applicability of Digital tools for Infectious Disease Surveillance in Community
Study Area / Country :
Nigeria
Quantifying the Added Value of Lunit Software in Advancing TB Elimination Efforts
Study Area / Country :
Vietnam
Understanding the End-user Perspectives of Implementing TB-CAD in High TB Burden Settings and Improving Fitness-for-Use in Children
Study Area / Country :
Vietnam, Mongolia

Receive RfP updates from the RIGHT Foundation by e-mail